Share Article
Foster City, Calif., August 3, 2026 – Gilead Sciences, Inc. announced today that the California State Supreme Court ruled in Gilead’s favor in the state court TDF litigation directing the trial court to enter judgment in Gilead’s favor on all claims.
Today’s decision is a victory for all those working to develop improved medical treatments and new medicines. The California Supreme Court's decision supports American innovation, allowing companies to continue pursuing breakthroughs for patients and consumers. Gilead is proud to have developed innovative, life-saving medicines that continue to be used by millions worldwide to prevent and treat HIV. We remain committed to ending the HIV epidemic through scientific innovation and a focus on the needs of people with HIV.
For more information about Gilead, please visit the company’s website at www.gilead.com, follow Gilead on X/Twitter (@Gilead Sciences) and LinkedIn (@Gilead-Sciences).
Investors
Jacquie Ross
investors_relations@gilead.com
Media Contact
Ashleigh Koss
public_affairs@gilead.com